ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY

USPTO (United States) · Serial 85164758

Status
abandoned
Status updated
13 January 2014
Filing date
29 October 2010
Registration date
-
Nice classification
42
Owner
Bristol-Myers Squibb Company
Owner country
US
Raw status code
606

As filed by US

Authoritative source

The official US trademark record is at USPTO TSDR (serial 85164758) ↗. Where our data differs from the USPTO record, theirs is correct.

See methodology for refresh cadence + status normalisation. See sources for licensing.